Business
With a reputation as the ‘pharmacy of the world,’ India is geared to mass-produce COVID-19 vaccines – ABC News
India has become a global powerhouse for generic pharmaceutical drugs and the hope is that this could make Indian companies like the Serum Institute, which is the…
While the Pfizer COVID-19 vaccine rollout in the United Kingdom and the United States has been widely heralded as the beginning of the end of the pandemic, much of the developing world has its hopes set elsewhere.
India has become a global powerhouse for generic pharmaceutical drugs and accounts for about 60 per cent of the world’s vaccine supplies, earning a reputation as the “pharmacy of the world”.
And unlike the Pfizer vaccine which is safe and effective but relatively expensive and unstable…
-
Noosa News18 hours agoWoman found dead in NSW police station car park feared she was being stalked, father says
-
General17 hours agoHundreds of men march against domestic violence in Alice Springs on Human Rights Day
-
Business24 hours agoIf You’d Invested $3,500 in Tesla 12 Years Ago, Here’s How Much You’d Have Today
-
General18 hours agoMan sentenced to six years’ jail for series of high-speed chases in Canberra
